Listen to Gynecologic Oncology
Listen to Gynecologic Oncology
Gynecologic Oncology
OS updates for Imagyn50
14 minutes Posted Nov 1, 2023 at 6:00 pm.
0:00
14:03
Download MP3
Show notes
Editor’s Choice: Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer Hosted by: Ursula Matulonis, MD, Associate Editor of Gynecologic Oncology Featuring: Kathleen N. Moore, MD, GOG-F and Stephenson Cancer Center at the University of Oklahoma Health Sciences Center Check out more content on the journal's homepage at https://www.gyn...